Goldman Sachs’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Goldman Sachs’s Portfolio NPSP Stock Details NPSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,243,113	Closed	-$44.5M	–	7541
2014 Q4	$44.5M	Buy	1,243,113 +851,657	+218%	+$25.4M	0.01%	1203
2014 Q3	$10.2M	Buy	391,456 +103,825	+36%	+$2.98M	﹤0.01%	2348
2014 Q2	$9.51M	Buy	287,631 +87,295	+44%	+$2.52M	﹤0.01%	2407
2014 Q1	$6M	Sell	200,336 -73,462	-27%	-$2.53M	﹤0.01%	2815
2013 Q4	$8.31M	Buy	273,798 +212,048	+343%	+$5.84M	﹤0.01%	2538
2013 Q3	$1.96M	Buy	61,750 +13,549	+28%	+$311K	﹤0.01%	3935
2013 Q2	$729K	Buy	+48,201	New	+$668K	﹤0.01%	4640

Other funds holding NPSP

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Goldman Sachs's NPSP Position: Q1 2015 in Review

Goldman Sachs sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 1,243,113 shares — an estimated $44.5M sold.

Goldman Sachs first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $44.5M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

Goldman Sachs reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Goldman Sachs sold 1,243,113 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $44.5M.
Goldman Sachs first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Goldman Sachs's NPS PHARMACEUTICALS INC position peaked at $44.5M in Q4 2014.
1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.